The Importance of Waiting for Biomarker Results in NSCLC

Episode
225
Soundcloud
Share

Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before starting therapy. In this episode of Lung Cancer Considered, host Dr. Stephen Liu guides a discussion about biomarkers and some of the challenges and issues they create. 

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Mark Kris
Mark Kris

MD

William and Joy Ruane Chair in Thoracic Oncology and Professor of Medicine
Weill Cornell Medical College
Aurora Lucas
Aurora Lucas
Lung Cancer Patient Advocate
EdD candidate
Ilit Turgeman
Ilit Turgeman

MD

Thoracic Medical Oncologist
Lin Medical Center and Carmel Hospital
IASLC Academy Alumnus
IASLC Global Policy Committee Member

Other Podcast